Phase IIT Trial of SNA014
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSmartNuclide Biopharma
About this trial
68Ga labeled Claudin 18.2 contrast agent combined with PET/CT for gastric or gastroesophageal junction
Eligibility criteria
Qualifiers
Age range of 18 to 75 years old (including boundary values);
Individuals with behavioral capacity who voluntarily participate in this clinical study and sign an informed consent form (ICF);
Diagnosed G/GEJ adenocarcinoma and pancreatic cancer;
Gastroscopy/CT/MRI/PET-CT examination results within the past month (if any);
Disqualifiers
Uncontrolled severe infections or individuals with other serious illnesses;
Those with an expected survival period of less than or equal to three months;
Pregnant or lactating patients, as well as reproductive age patients who refuse to take appropriate contraceptive measures during this trial;
investigators determine that patients who are not suitable to participate in this study;
Trial design
Treatments tested in this trial
- [68Ga]Ga-NODAGA-SNA014
Treatment groups
28 Participants
are divided into 1 treatment groupLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
The First Affiliated Hospital of Soochow University Status unavailable 215000, Jiangsu, Province
China
ChinaSponsors and collaborators
Source ClinicalTrials.gov